Clinicopathological significance of 5'-3' exoribonuclease 2 expression in small cell lung cancer tissues
{{output}}
Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy. Overall survival in SCLC patients remains poor, and there is a lack of treatment options after the failure of first-line therapy. 5'-3' exoribonuclease 2 (XRN2) is associated with tumo... ...
